InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Hirawat Samit, Directeur Médical. Insider active across 1 companies, notably Bristol Myers Squibb Co. In total, 3 disclosures have been published. The latest transaction was disclosed on 10 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
04,189 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000072:0·
09,356 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000182·
09,356 shares0
Common Stock, $0.10 par value
SEC:0000014272-21-000182:0·
3 of 3 declarations
About Hirawat Samit
Samit Hirawat is Executive Vice President and Chief Medical Officer, Drug Development at BRISTOL MYERS SQUIBB CO. He oversees drug research and development initiatives. His expertise is essential in ensuring innovation and safety in the treatments offered.
